Edwards Lifesciences (EW) News Today → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free EW Stock Alerts $89.14 -0.97 (-1.08%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 12:31 AM | marketbeat.comFiera Capital Corp Has $67.79 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Fiera Capital Corp lifted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 31.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 889,064 shares of the medical research company's stock after buying an additioMay 16 at 11:57 PM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by EFG Asset Management North America Corp.EFG Asset Management North America Corp. increased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 122.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,767 shares of the mMay 16 at 4:58 PM | benzinga.comEdwards Lifesciences's Options: A Look at What the Big Money is ThinkingMay 16 at 7:10 AM | marketbeat.comEdwards Lifesciences Q1 Earnings TranscriptMay 16 at 5:16 AM | americanbankingnews.comDeutsche Bank Aktiengesellschaft Upgrades Edwards Lifesciences (NYSE:EW) to BuyMay 15 at 4:53 PM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Short Interest Up 30.5% in AprilEdwards Lifesciences Co. (NYSE:EW - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 9,630,000 shares, a growth of 30.5% from the April 15th total of 7,380,000 shares. Approximately 1.6% of the shares of the stock are sold short. Based on an average daily volume of 3,550,000 shares, the short-interest ratio is presently 2.7 days.May 15 at 4:25 PM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $43.76 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 598,326 shares of the medical research company's stockMay 15 at 4:12 PM | msn.comDeutsche Bank Upgrades Edwards Lifesciences (EW)May 14, 2024 | marketbeat.comCCLA Investment Management Sells 1,279,930 Shares of Edwards Lifesciences Co. (NYSE:EW)CCLA Investment Management lessened its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 99.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,395 shares of the medical research company's stock after selling 1,279,9May 14, 2024 | finance.yahoo.comIndian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust ComplaintMay 14, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Upgraded at Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft upgraded shares of Edwards Lifesciences from a "hold" rating to a "buy" rating in a research note on Tuesday.May 14, 2024 | americanbankingnews.comEdwards Lifesciences Co. (NYSE:EW) VP Donald E. Bobo, Jr. Sells 5,000 Shares of StockMay 14, 2024 | insidertrades.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells $439,050.00 in StockMay 13, 2024 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 5,000 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Donald E. Bobo, Jr. sold 5,000 shares of the business's stock in a transaction on Friday, May 10th. The shares were sold at an average price of $87.81, for a total transaction of $439,050.00. Following the sale, the vice president now owns 47,750 shares of the company's stock, valued at $4,192,927.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.May 13, 2024 | msn.comIndia's Meril files EU antitrust complaint against Edwards: reportMay 13, 2024 | sg.finance.yahoo.comEdwards Lifesciences hit with Meril's EU antitrust complaintMay 11, 2024 | finance.yahoo.comInvestors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five yearsMay 11, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Los Angeles Capital Management LLCLos Angeles Capital Management LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 92.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,479 shares of the medical research company's stock afteMay 10, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $73,359.20 in StockMay 9, 2024 | marketbeat.comGDS Wealth Management Buys 90,328 Shares of Edwards Lifesciences Co. (NYSE:EW)GDS Wealth Management grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 98.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 182,209 shares of the medical research company's stock afteMay 9, 2024 | americanbankingnews.comEdwards Lifesciences (NYSE:EW) PT Raised to $101.00May 9, 2024 | seekingalpha.comEdwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)May 8, 2024 | finance.yahoo.comEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityMay 8, 2024 | marketbeat.comNational Bank of Canada FI Raises Position in Edwards Lifesciences Co. (NYSE:EW)National Bank of Canada FI lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 214,861 shares of the medical research company's stock aMay 8, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) CEO Buys $49,729.20 in StockMay 7, 2024 | marketbeat.comInsider Buying: Edwards Lifesciences Co. (NYSE:EW) CEO Buys 580 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) CEO Bernard J. Zovighian purchased 580 shares of the business's stock in a transaction dated Monday, May 6th. The shares were purchased at an average price of $85.74 per share, for a total transaction of $49,729.20. Following the acquisition, the chief executive officer now directly owns 3,268 shares of the company's stock, valued at $280,198.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.May 7, 2024 | markets.businessinsider.comAssessing Edwards Lifesciences: Insights From 11 Financial AnalystsMay 7, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Price Target Raised to $101.00Barclays boosted their target price on Edwards Lifesciences from $100.00 to $101.00 and gave the company an "overweight" rating in a research report on Tuesday.May 7, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by M&T Bank CorpM&T Bank Corp lessened its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 28.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 71,727 shares of the medical research company's stock after selling 29,194 shares duMay 6, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Spire Wealth ManagementSpire Wealth Management raised its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 40.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,351 shares of the medical research coMay 4, 2024 | marketbeat.comAmalgamated Bank Sells 10,327 Shares of Edwards Lifesciences Co. (NYSE:EW)Amalgamated Bank decreased its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 151,370 shares of the medical research company's stock after selliMay 3, 2024 | marketbeat.comFisher Asset Management LLC Lowers Position in Edwards Lifesciences Co. (NYSE:EW)Fisher Asset Management LLC lowered its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,133,892 shares of the medical reMay 3, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) Director Sells $2,487,999.50 in StockMay 2, 2024 | marketbeat.comLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $11.59 Million Stake in Edwards Lifesciences Co. (NYSE:EW)Loring Wolcott & Coolidge Fiduciary Advisors LLP MA decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 28.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 133,302 shares of the medical reseaMay 2, 2024 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) Director Sells 29,350 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) Director Michael A. Mussallem sold 29,350 shares of Edwards Lifesciences stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $84.77, for a total transaction of $2,487,999.50. Following the transaction, the director now directly owns 4,486 shares in the company, valued at $380,278.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.May 2, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $1,212,624.00 in StockMay 1, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Has $109.38 Million Stake in Edwards Lifesciences Co. (NYSE:EW)Raymond James Financial Services Advisors Inc. boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,144,581 shares oMay 1, 2024 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 14,400 Shares of StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Jean-Luc M. Lemercier sold 14,400 shares of Edwards Lifesciences stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $84.21, for a total transaction of $1,212,624.00. Following the completion of the sale, the vice president now owns 173,849 shares of the company's stock, valued at $14,639,824.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.May 1, 2024 | insidertrades.comEdwards Lifesciences Co. (NYSE:EW) CFO Scott B. Ullem Sells 7,250 SharesApril 30, 2024 | marketbeat.comScott B. Ullem Sells 7,250 Shares of Edwards Lifesciences Co. (NYSE:EW) StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) CFO Scott B. Ullem sold 7,250 shares of the firm's stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $85.80, for a total value of $622,050.00. Following the sale, the chief financial officer now directly owns 19,074 shares in the company, valued at approximately $1,636,549.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.April 30, 2024 | finance.yahoo.comEdwards Lifesciences Corporation (NYSE:EW) Q1 2024 Earnings Call TranscriptApril 30, 2024 | markets.businessinsider.comHold Rating Justified for Edwards Lifesciences Amid TAVR Segment UncertaintiesApril 30, 2024 | marketbeat.comInvera Wealth Advisors LLC Has $2.97 Million Position in Edwards Lifesciences Co. (NYSE:EW)Invera Wealth Advisors LLC increased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 70.1% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 31,078 shares of the medical research company's stock after purchasing an additional 12,809 sApril 29, 2024 | marketbeat.comStockNews.com Upgrades Edwards Lifesciences (NYSE:EW) to BuyStockNews.com raised Edwards Lifesciences from a "hold" rating to a "buy" rating in a research report on Monday.April 28, 2024 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by Russell Investments Group Ltd.Russell Investments Group Ltd. lifted its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 15.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,120,025 shares of the medical research company's stoApril 27, 2024 | marketbeat.comOwnership Capital B.V. Has $266.11 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Ownership Capital B.V. raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 21.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,489,915 shares of the medical research companApril 27, 2024 | finance.yahoo.comEdwards Lifesciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsApril 27, 2024 | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)April 26, 2024 | marketbeat.comEdwards Lifesciences (NYSE:EW) Trading Down 3.7% Following Analyst DowngradeEdwards Lifesciences (NYSE:EW) Stock Price Down 3.7% After Analyst DowngradeApril 26, 2024 | marketbeat.comWells Fargo & Company Raises Edwards Lifesciences (NYSE:EW) Price Target to $99.00Wells Fargo & Company raised their target price on shares of Edwards Lifesciences from $94.00 to $99.00 and gave the company an "overweight" rating in a research note on Friday. Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… EW Media Mentions By Week EW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼0.770.50▲Average Medical News Sentiment EW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼1811▲EW Articles Average Week Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STERIS News Intuitive Surgical News Zimmer Biomet News Align Technology News DexCom News Moderna News Cencora News Takeda Pharmaceutical News IQVIA News Centene News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
